The study, published in the British Medical Journal, analyzed electronic health records for approximately 10.2 million vaccinated and 10.4 unvaccinated people in the U.K., Spain and Estonia.
Researchers found reduced risk for cardiac and thromboembolic outcome following a COVID-19 infection if the person was vaccinated.
“These effects were more pronounced for acute COVID-19 outcomes, consistent with known reductions in disease severity following breakthrough versus unvaccinated SARS-CoV-2 infection,” the study authors wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
